What is Corynebacterium amycolatum and how is it acquired?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Corynebacterium amycolatum: Organism Characteristics and Acquisition

Corynebacterium amycolatum is a saprophytic, Gram-positive bacterium that normally colonizes human skin but has emerged as an opportunistic pathogen primarily in hospitalized, immunocompromised patients with prolonged instrumentation. 1, 2

What is Corynebacterium amycolatum?

C. amycolatum is a non-spore-forming, mycolic acid-free, aerobic or facultative anaerobic bacillus belonging to the nonlipophilic fermentative group of corynebacteria 1, 2. While traditionally considered normal skin flora, it is now recognized as an emerging pathogen capable of causing serious infections including:

  • Bacteremia and endocarditis 2, 3
  • Catheter-related bloodstream infections 4
  • Cardiovascular implantable electronic device (CIED) infections 4

The organism shares characteristics with other Corynebacterium species (C. striatum, C. minutissimum, C. xerosis) but can be distinguished through molecular methods targeting the divIVA gene 1.

How is it Acquired?

Primary Acquisition Routes:

Endogenous transmission from patient's own skin flora is the predominant mechanism 4. The organism colonizes normal skin and transitions to pathogenicity when host defenses are compromised or when invasive devices breach the skin barrier.

Exogenous transmission occurs through:

  • Hospital inanimate environment 4
  • Hands of healthcare workers 4
  • Contaminated medical devices and equipment

High-Risk Clinical Scenarios:

Acquisition leading to infection typically occurs in patients with:

  1. Prolonged hospitalization with multiple invasive procedures 3
  2. Indwelling vascular catheters (central venous, peripheral, PICC lines) 4, 5, 6
  3. Cardiovascular implantable devices (pacemakers, defibrillators) 4
  4. Severe underlying disease or immunosuppression 1, 3
  5. Multi-instrumentation (multiple invasive devices simultaneously) 3

Pathogenic Mechanisms:

The transition from colonization to infection involves:

  • Biofilm formation on foreign materials and devices 4
  • Adherence to host matrix proteins (fibrinogen, fibronectin, collagen) deposited on implanted biomaterials 4
  • Acquisition of antimicrobial resistance genes through genomic islands, contributing to multidrug resistance 7
  • Immune evasion mechanisms and antiphagocytosis factors 7

Important Clinical Caveats:

Repeated isolation is essential for diagnosis 4. Since Corynebacterium species are common skin contaminants, at least 2 positive blood cultures from different sites with identical antibiotic susceptibility patterns are required to confirm true infection rather than contamination 5, 8.

Healthcare-associated acquisition predominates 4. The disproportionate frequency of multidrug-resistant strains in CIED and catheter-related infections strongly suggests healthcare environments as the primary acquisition site rather than community settings 4.

The organism's ability to produce and share cobamides (vitamin B12 cofactors) may facilitate its persistence within polymicrobial skin communities 9, potentially explaining its successful colonization and subsequent opportunistic behavior in vulnerable hosts.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.